Helen Kim Selected Research

Arteriovenous Malformations (Arteriovenous Malformation)

1/2022	Endoluminal Biopsy for Molecular Profiling of Human Brain Vascular Malformations.
1/2021	Pilot investigation of circulating angiogenic and inflammatory biomarkers associated with vascular malformations.
1/2021	Proof-of-concept single-arm trial of bevacizumab therapy for brain arteriovenous malformation.
1/2020	Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA): final follow-up of a multicentre, non-blinded, randomised controlled trial.
12/2019	Angiopoietin-2 predicts morbidity in adults with Fontan physiology.
10/2017	Functional impairments for outcomes in a randomized trial of unruptured brain AVMs.
10/2017	Higher Flow Is Present in Unruptured Arteriovenous Malformations With Silent Intralesional Microhemorrhages.
4/2015	Current surgical results with low-grade brain arteriovenous malformations.
1/2014	Distinctive distribution of lymphocytes in unruptured and previously untreated brain arteriovenous malformation.
6/2013	Polymorphisms in ACVRL1 and endoglin genes are not associated with sporadic and HHT-related brain AVMs in Dutch patients.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Helen Kim Research Topics

Disease

19	Arteriovenous Malformations (Arteriovenous Malformation) 01/2022 - 10/2007
12	Breast Neoplasms (Breast Cancer) 05/2015 - 01/2003
11	Hemorrhage 01/2021 - 10/2007
10	Alzheimer Disease (Alzheimer's Disease) 09/2007 - 12/2003
9	Neoplasms (Cancer) 05/2015 - 01/2002
6	Stroke (Strokes) 01/2022 - 12/2011
4	Hereditary Hemorrhagic Telangiectasia 01/2021 - 09/2010
4	Central Nervous System Cavernous Hemangioma 01/2020 - 03/2016
4	Rupture 12/2011 - 01/2009
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 04/2005 - 01/2002
3	Vascular Malformations 01/2022 - 04/2013
3	Inflammation (Inflammations) 01/2021 - 12/2004
3	Vascular Remodeling 01/2021 - 01/2008
3	Hypertension (High Blood Pressure) 01/2014 - 09/2005
3	Body Weight (Weight, Body) 12/2013 - 12/2004
3	Carcinogenesis 02/2011 - 12/2004
3	Amyloid Plaque 11/2006 - 05/2006
2	Intracranial Aneurysm (Cerebral Aneurysm) 12/2020 - 01/2008
2	Brain Injuries (Brain Injury) 07/2014 - 07/2010
2	Central Nervous System Vascular Malformations (Dural Arteriovenous Fistula) 04/2013 - 01/2008
2	Cognitive Dysfunction 07/2010 - 03/2006
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 03/2009 - 10/2007
2	Atherosclerosis 01/2009 - 12/2003
2	Dementia (Dementias) 03/2006 - 11/2005
2	Hodgkin Disease (Hodgkin's Disease) 01/2004 - 09/2003
1	Ischemic Stroke 01/2022
1	Sarcoma (Soft Tissue Sarcoma) 12/2021
1	Familial cerebral cavernous malformation 01/2021
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2021
1	Cavernous Hemangioma (Cavernous Angioma) 01/2021
1	Edema (Dropsy) 12/2019
1	Varicose Veins (Varicose Vein) 10/2017
1	Testicular Neoplasms (Testicular Cancer) 09/2015
1	Melanoma (Melanoma, Malignant) 09/2015
1	Cerebral Hemorrhage 01/2014
1	Hyperlipidemias (Hyperlipidemia) 01/2014
1	Obesity 01/2014
1	Disease Progression 04/2013
1	Pulmonary Edema 12/2012
1	Aneurysm (Aneurysms) 05/2012

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2003
9	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2009
5	PolyphenolsIBA 08/2010 - 12/2004
4	EndoglinIBA 07/2014 - 07/2009
3	Mitogen-Activated Protein KinasesIBA 01/2022 - 12/2021
3	IronIBA 01/2021 - 01/2014
3	HemosiderinIBA 10/2017 - 05/2012
3	Peptides (Polypeptides)IBA 09/2015 - 01/2003
3	Activin Receptors (Activin Receptor)IBA 06/2013 - 03/2009
3	Estrogens (Estrogen)FDA Link 08/2010 - 09/2005
3	Grape Seed ExtractIBA 03/2009 - 12/2004
3	CholesterolIBA 12/2006 - 12/2003
3	AntibodiesIBA 09/2006 - 11/2004
2	Pharmaceutical PreparationsIBA 12/2020 - 12/2006
2	Simvastatin (Zocor)FDA LinkGeneric 01/2020 - 12/2006
2	Matrix Metalloproteinases (MMPs)IBA 03/2016 - 07/2009
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 03/2016 - 10/2005
2	Selective Estrogen Receptor Modulators (SERM)IBA 10/2011 - 12/2007
2	Hormones (Hormone)IBA 10/2011 - 08/2010
2	Estrogen ReceptorsIBA 10/2011 - 07/2010
2	SteroidsIBA 08/2010 - 09/2003
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2009 - 10/2007
2	Apolipoproteins E (ApoE)IBA 03/2009 - 10/2007
2	Immunoglobulins (Immunoglobulin)IBA 09/2006 - 05/2006
2	Amyloid beta-PeptidesIBA 05/2006 - 11/2004
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2005 - 02/2004
2	GenisteinIBA 12/2004 - 01/2003
2	Monoclonal AntibodiesIBA 02/2004 - 01/2002
1	Bevacizumab (Avastin)FDA Link 01/2021
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2021
1	Dinoprostone (PGE2)FDA Link 01/2021
1	Gonadal Steroid Hormones (Sex Hormones)IBA 12/2020
1	Anticonvulsants (Antiepileptic Drugs)IBA 12/2020
1	thiamine triphosphorate (TTP)IBA 10/2017
1	VaccinesIBA 09/2015
1	AntigensIBA 09/2015
1	Complement System Proteins (Complement)IBA 05/2015
1	Hemoglobins (Hemoglobin)IBA 05/2015
1	Oxygen (Dioxygen)IBA 05/2015
1	LipidsIBA 01/2014
1	Indicators and Reagents (Reagents)IBA 01/2014
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2014
1	dimemorfan (AT 17)IBA 12/2013
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2013
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2012
1	EnzymesIBA 12/2012
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 08/2012
1	perlecanIBA 07/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2012
1	ParaffinIBA 05/2012
1	Hematoxylin (Haematoxylon)IBA 05/2012
1	Eosine Yellowish-(YS) (Eosin)IBA 05/2012
1	bazedoxifeneIBA 10/2011

Therapy/Procedure

19	Therapeutics 01/2022 - 01/2002
2	Transplantation 08/2010 - 01/2002
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 04/2005 - 02/2004
2	Drug Therapy (Chemotherapy) 01/2005 - 01/2002
1	Fontan Procedure (Fontan Operation) 12/2019
1	Aftercare (After-Treatment) 08/2016
1	Neoadjuvant Therapy 05/2015